Cambridge Biomedical EIS Fund

October 14, 2020  biotech, FinTech, Green Technology, GreenTech, Investments, meditech, PropTech

Cambridge Biomedical EIS Fund

We have been very bullish about the prospects of the Cambridges property market and our latest development here is nearly fully funded.

We selected the development due to it’s close proximity to the Biomedical Campus and the AstraZeneca building.

Money continues to flow into the Biomedical Campus, the government has just committed another £120 million for a new cancer research hospital right next to the AstraZeneca building and a short walk from our development. This will create more jobs and demand for accommodation in the area.

Cambridge Biomedical Campus

New Cancer Research Centre Cambridge
New Cancer Research Centre Cambridge

 

Off the back of our time spent in Cambridge we have been introduced to a Biomedical Enterprise Investment Scheme Fund. The fund has been designed to find and invest in early stage biotech companies, with an emphasis on Artificial Intelligence in Cambridge.

The Cambridge based office has a wealth of experience in angel investing and Cambridge Biomedical start ups and they already have a good track record of picking winners.

We are very pleased to be working with them and hope our clients will too.

EIS Relief available

The fund will invest in SEIS and EIS qualified companies. EIS/SEIS is a tax relief scheme created by the UK Government to encourage investment in seed-stage startups and businesses.

If eligible, you can claim back up to 50% of the value of your investment in the form of income tax relief. Therefore, if you make an investment of £100,000, you can save £50,000 in income tax.

The combination of tax relief and arguably the worlds most important industry in the wake of Covid-19 makes this a very compelling investment.

Cambridge Biomedical EIS Fund

Subscribe to receive updates!

Click below to listen to the Willow Rivers Podcasts